(Adds background, updates shares)
Feb 22 (Reuters) - Charles River Laboratories CRL.N said on Wednesday
that it had received a subpoena from the U.S. Department of Justice over an
investigation into the supply of non-human primates from Cambodia, which are a
part of the animal research services that the company offers to drug developers.
Shares of the company were down 12.4% at $213.34.
The DoJ had in November charged members of an international primate
smuggling ring with multiple felonies for their role in bringing wild
long-tailed macaques into the United States.
Charles River expects constraints on the supply of monkeys to reduce its
consolidated revenue growth forecast by about 200 to 400 basis points this year.
The company on Wednesday forecast revenue growth of 1.5% to 4.5% for 2023.
Long-tailed macaques are protected under the Convention on International
Trade in Endangered Species of Wild Fauna and Flora (CITES) and require special
permits in order to be imported into the United States.
The company also said it had also voluntarily suspended shipments of
non-human primates from Cambodia at this time.
In November last year, contract drug researcher Inotiv Inc NOTV.O
disclosed that executives at its main supplier in Cambodia were charged with
violations of U.S. endangered species law for illegally importing non-human
primates.
Non-human primates are essential in animal models in biomedical research.
(Reporting by Sriparna Roy in Bengaluru; Editing by Anil D'Silva and Shailesh
Kuber)
((Sriparna.Roy@thomsonreuters.com;))